Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis
The Effectiveness of ECP in Diffuse Cutaneous Systemic Sclerosis
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Listed as NCT04986605, this PHASE2 trial focuses on Diffuse Cutaneous Systemic Sclerosis and remains actively recruiting participants. Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, it has been updated 10 times since 2025, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Not Yet Recruiting PHASE2
-
Jan 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
▶ Show 5 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2023 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
-
May 2022 — Apr 2023 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2021 — May 2022 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Mallinckrodt
For direct contact, visit the study record on ClinicalTrials.gov .